- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Nonsmall-cell Lung Cancer in United Kingdom
Total 7369 results
-
Abramson Cancer Center of the University of PennsylvaniaCompletedMetastatic Non Small Cell Lung Cancer | Recurrent Non Small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedExtensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung CancerUnited States
-
Washington University School of MedicineRecruitingSmall Cell Lung Carcinoma | Small-cell Lung CancerUnited States
-
Brown UniversityBristol-Myers SquibbRecruitingNon Small Cell Lung CancerUnited States
-
University of RochesterRecruiting
-
Albert Einstein College of MedicineCelldex TherapeuticsTerminatedLung Cancer | Non Small Cell Lung CancerUnited States
-
Loyola UniversityActive, not recruitingNon Small Cell Lung CancerUnited States
-
The University of Texas Health Science Center at...Faron Pharmaceuticals LtdWithdrawnNon-small Cell Lung CancerUnited States
-
ImmunityBio, Inc.Withdrawn
-
Jonsson Comprehensive Cancer CenterTerminatedNon Small Cell Lung CancerUnited States
-
Clovis Oncology, Inc.Genentech, Inc.TerminatedNon-small Cell Lung CancerUnited States
-
Duke UniversitySanofiTerminatedNon-small Cell Lung CancerUnited States
-
NovaRx CorporationNo longer availableNon-small Cell Lung CancerUnited States
-
NovaRx CorporationCompletedLung Neoplasm | Carcinoma Non-small Cell Lung Cancer Stage IIIA | Carcinoma Non-small Cell Lung Cancer Stage IIIB | Carcinoma Non-small Cell Lung Cancer Stage IVUnited States, Hungary, United Kingdom, Netherlands, Canada, India, Poland, Serbia
-
Kartos Therapeutics, Inc.TerminatedSmall Cell Lung Carcinoma | Small-cell Lung Cancer | Small Cell Lung Cancer Extensive Stage | Small Cell Lung Cancer RecurrentGermany, Spain, France, Australia, United States, Korea, Republic of, Hungary
-
Roswell Park Cancer InstituteCompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung CarcinomaUnited States
-
Edward PatzActive, not recruitingNon-small Cell Lung CancerUnited States
-
Roswell Park Cancer InstituteActive, not recruitingStage IB Non-Small Cell Lung Carcinoma AJCC v7 | Stage II Non-Small Cell Lung Cancer AJCC v7 | Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIIA Non-Small Cell Lung Cancer AJCC v7 | Stage I Non-Small Cell Lung Cancer AJCC v7 | Stage...United States
-
Georgetown UniversityRegeneron PharmaceuticalsNot yet recruitingNon-small Cell Lung Cancer Stage IIIUnited States
-
Regeneron PharmaceuticalsRecruiting
-
AstraZenecaActive, not recruitingNon-small Cell Lung Cancer NSCLCUnited Kingdom, Belgium, United States, Korea, Republic of, Hungary, Japan, Russian Federation, Poland, Ukraine, India, Mexico, Netherlands
-
MedImmune LLCCompletedNSCLC | Lung Cancer | Non-small Cell Lung CancerUnited States, France, Italy, Spain, Belgium, United Kingdom, Korea, Republic of, Australia, Taiwan
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Malignant Pleural EffusionUnited States
-
Stanford UniversityNational Cancer Institute (NCI)CompletedAnxiety Disorder | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
VA Office of Research and DevelopmentVA Greater Los Angeles Healthcare SystemNot yet recruitingEZH2 Inhibitor, Tazemetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung CancerNon Small Cell Lung CancerUnited States
-
Taofeek OwonikokoNational Cancer Institute (NCI); Cardiff OncologyActive, not recruitingSmall Cell Lung Carcinoma | Small-cell Lung CancerUnited States
-
Cyclacel Pharmaceuticals, Inc.TerminatedNon-small Cell Lung CancerUnited States
-
Wake Forest University Health SciencesTerminatedNon-small Cell Lung CancerUnited States
-
University of UtahBristol-Myers SquibbCompletedNon-small Cell Lung CancerUnited States
-
National Cancer Institute (NCI)TerminatedNon-Small-Cell Lung CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Stage IIA Non-Small Cell Lung Carcinoma | Stage IIB Non-Small Cell Lung Carcinoma | Stage IA Non-Small Cell Lung Carcinoma | Stage IB Non-Small Cell Lung CarcinomaUnited States
-
AstraZenecaCompletedRefractory Solid Tumours | Relapsed Small Cell Lung Cancer (SCLC)United States, Canada
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerSpain, France, United States, United Kingdom, Latvia, Italy, Israel, Argentina, Germany
-
University of California, San FranciscoNovartis Pharmaceuticals; University of California, DavisTerminatedNon-small Cell Lung CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Guardant Health, Inc.CompletedChanges in Circulating Tumor-Specific DNA in Patients With Non-Metastatic Non-Small Cell Lung CancerNon Small Cell Lung CancerUnited States
-
Giuseppe GiacconeMemorial Sloan Kettering Cancer Center; Vanderbilt UniversityTerminatedSmall Cell Lung Cancer ( SCLC )United States
-
University of North Carolina, Chapel HillUniversity of South Carolina; East Carolina UniversityCompletedNon-small Cell Lung CancerUnited States
-
Optimum Therapeutics, LLCTerminatedNon-small Cell Lung CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedStage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Medical College of WisconsinNot yet recruitingNon Small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterTerminated
-
University of ChicagoTerminatedNon-small Cell Lung CancerUnited States
-
SanofiCompletedSmall Cell Lung Cancer | Lung Cancer | Pulmonary NeoplasmsFrance, Brazil, Poland, Russian Federation, Australia, Germany, Italy, Spain, Belgium, Mexico, Argentina, Hungary, United Kingdom, Netherlands
-
University of ChicagoNational Cancer Institute (NCI)TerminatedExtensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung CancerUnited States
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Squamous Non Small Cell Lung Cancer | Nonsquamous Non Small Cell Lung CancerPhilippines, Thailand, France, Korea, Republic of, Hong Kong, United States, Turkey, Malaysia, Taiwan, Brazil, Serbia, Greece, Slovakia, Peru, South Africa, Mexico, Vietnam, Bangladesh
-
AmgenRecruitingSmall-Cell Lung Cancer | Extensive-Stage Small-Cell Lung CancerUnited States, China, Japan, Switzerland, Turkey
-
Duke UniversityRegeneron PharmaceuticalsRecruitingNon-small Cell Lung Cancer (NSCLC)United States
-
M.D. Anderson Cancer CenterTerminatedStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Metastatic Lung Non-Squamous Non-Small Cell Carcinoma | Stage IIIC Lung Cancer AJCC v8 | Unresectable Lung... and other conditionsUnited States
-
Taofeek OwonikokoAstraZenecaRecruitingExtensive-stage Small-cell Lung CancerUnited States
-
University of Texas Southwestern Medical CenterRecruitingAdvanced Squamous Non Small Cell Lung CancerUnited States